Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Pharmacokinetic study of temoporfin-loaded invasomes after their in vivo topical application onto mice bearing subcutaneously implanted ht29 tumour
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: IPS-004
- By: DRAGICEVIC, Nina (Department of Pharmacy, Singidunum University, Serbia)
- Co-author(s): Prof Nina Dragicevic, Head Of The Department Of Pharmacy (Department of Pharmacy, Singidunum University, Belgrade, Serbia)
Mag.pharm. Katarina Milosevic-Kostadinovic, Apoteka "Medicor" Dobrota (Apoteka "Medicor", Kotor, Montenegro)
Prof. Alfred Fahr, Department of Pharmaceutical Technology (Department of Pharmaceutical Technology, Friedrich Schiller University Jena, Jena, Germany)
Background: Temoporfin (mTHPC) has a great potential for the topical photodynamic therapy. However, it presents a highly hydrophobic second generation photosensitizer with low percutaneous penetration. In order to use mTHPC for dermal/transdermal delivery it is necessary to employ some of the penetration enhancement methods.
Aim: The goal was to.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019